Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study

Fiona Blackhall, Fiona H. Blackhall, Dennis A. Wigle, Igor Jurisica, Melania Pintilie, Ni Liu, Gail Darling, Michael R. Johnston, Shaf Keshavjee, Thomas Waddell, Timothy Winton, Frances A. Shepherd, Ming Sound Tsao

    Research output: Contribution to journalArticlepeer-review

    Abstract

    We previously reported that our cDNA microarray analysis of primary non-small cell lung carcinoma (NSCLC) could predict for patients at increased risk of cancer recurrence. From the result of this analysis, we selected 11 genes that were considered candidate prognostic marker genes and used the realtime reverse transcription polymerase chain reaction (RT-PCR) to investigate their expression in the same set of NSCLC cases used in the microarray study. Cluster analysis of the realtime RT-PCR data separated these patients into two groups with significantly different disease-free survivals (log-rank test, P
    Original languageEnglish
    Pages (from-to)197-204
    Number of pages7
    JournalLung Cancer
    Volume46
    Issue number2
    DOIs
    Publication statusPublished - Nov 2004

    Keywords

    • Microarray
    • Prognostic markers, lung cancer
    • Realtime RT-PCR

    Fingerprint

    Dive into the research topics of 'Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study'. Together they form a unique fingerprint.

    Cite this